2022 Boston University Ophthalmology Update and Haimovici Symposium

Boston, MA US
April 8, 2022 to April 9, 2022

Back in Person in Boston.

The 2022 Boston University Ophthalmology Update and Haimovici Symposium is designed for practicing ophthalmologists, optometrists, ophthalmic technicians and medical personnel involved in the diagnosis and treatment of eye disease. In this program, national and departmental experts will discuss the most advanced medical and surgical treatment options for ophthalmic conditions such as retinal diseases, neuro-ophthalmology, plastics, glaucoma, cornea, pediatric ophthalmology, strabismus and amblyopia This conference is designed to address gaps in knowledge and competence in these areas.

It also includes the Haimovici Lecture. Named in honor of Robert Haimovici, MD, beloved retina specialist who served as the Director of the Retina Service at Boston Medical Center and BUSM from 1994 until his death in 2002, this lecture honors his dedication and professionalism and his deep commitment to education.

COVID-19 Safety Precautions

Update 4/4 - Masks will be required in the meeting areas with the exception of the exhibitor and break areas where masks are encouraged but optional." All attendees will be expected to be up to date on COVID-19 vaccinations.

Please note we will be following all Boston University and City of Boston event and meeting protocols to ensure the health and safety of all attendees, staff, and the local community and will update all attendees on these protocols as we get closer to the meeting date.  In person attendees must attest that they have been fully vaccinated (14 days since last dose) before attending the meeting and bring their vaccination card with them.  If you will not be fully vaccinated or feel ill on the day, we respectfully ask that you do not attend (a refund will be issued)

 

This program is supported in part by educational grants from:

  • Alcon Vision, LLC
  • Genentech, Inc.
  • Horizon Therapeutics USA , Inc.
  • This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 

The following will be exhibiting at the meeting:

  • Alcon
  • Allergan
  • Glaukos
  • Heidelberg Engineering, Inc.
  • Horizon Therapeutics USA , Inc.
  • New World Medical
  • Sanofi
  • SightSciences

 

Target Audience

This program is for ophthalmologists, optometrists, ophthalmic technicians, and the healthcare team involved in the diagnosis and treatment of eye disease.

Learning Objectives

At the end of this program, participants should be able to:

  1. Discuss the primaty outcomes of the Zoster Eye Disease Study.
  2. Discuss IOL options and updates in IOL technology
  3. Review complications unique to FLACS in order to provide the patients the best possible outcomes.
  4. Discuss the different types of MIGS procedures including how to incorporate MIGS into a comprehensive ophthalmology practice.
  5. Discuss updates in Humphrey Visual Field testing Strategies and visual field technology.
  6. Discuss updates in Optical Coherence Tomography (OCT) 
  7. Discuss how these technologies are best used to facilitate care of glaucoma patients individually and in tandem
  8. Identify the new glaucoma medications and discuss when to use them and their adverse events.
  9. Choose and provide appropriate treatment for issues related to glaucoma.
  10. Identify risk factors for development of diplopia after implantation of hardware for management of glaucoma and retinal detachment.   
  11. Identify pars planitis and features that necessitate treatment.
  12. Describe common eyelid masses including differentiating between benign and malignant eyelid lesions and their management options. 
  13. Recognize distinguishing features of active thyroid eye disease (signs and symptoms) and become more familiar with indications for several of the treatment options available to TED patients.
  14. Discuss evidence-based treatment of diabetic retinopathy in the era of anti-vascular endothelial growth factor and improved imaging modalities.
  15. Compare results of clinical trials to real-world clinical practice in the treatment of age-related macular degeneration and diabetic retinopathy and highlight causes of discrepancies.
  16. Discuss novel strategies to reduce the treatment burden of intravitreal injections of anti VEGF medications for chorioretinal vascular disease
  17. Review of ocular imaging and protein biomarkers and the eye's potential role in diagnosis of Alzheimer's Disease.
  18. Review the impact and challenges in AMD.
  19. Review pathogenesis and risk factors of AMD
Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Live activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 5.50 Participation
Course opens: 
12/13/2021
Course expires: 
04/09/2023
Event starts: 
04/08/2022 - 1:00pm EDT
Event ends: 
04/09/2022 - 11:20am EDT
Cost:
$250.00
Rating: 
0
Friday, April 8, 2022
12:15 PMRegistration
1:00 PMWelcome and Introduction - Stephen P. Christiansen, MD
1:10 PMZEDS: the Zoster Eye Disease Study - Christine Ament MD
1:25 PMChoice Overload? IOL Selection Challenges – Rachel Robbin, MD
1:40 PMA Potpourri of FLACS Complications - Kambiz Negahban, MD
2:25 PMBreak
3:00 PMRole of MIGS in Glaucoma Manangement: Hype or Real - Babak Eliassi-Rad, MD
3:15 PMOCT is Here, Do We Still Need Visual Fields?  - Manishi A. Desai, MD
3:30 PMThe Latest and Greatest Glaucoma Medications - Haben F. Kefella, MD, MHS
3:45 PMGlaucoma Panel - Babak Eliassi-Rad, MD, Manishi A. Desai, MD, Haben F. Kefella, MD, MHS
4:00 PMRestrictive Strabismus: Tubes and Buckles - Stephen P. Christiansen, MD
4:15 PMPars Planitis: What it is and When to Treat It - KC LaMattina, MD
4:30 PMEyelid Lumps and Bumps - Alberto Distefano, MD
4:45 PMWhen Graves Means Danger: Update on Thyroid Eye Disease - Anna C. Kupcha, MD
5:00 PMAdjourn/Reception
Saturday, April 9, 2022
7:15 AMRegistration and Continental Breakfast
8:00 AMIntroduction - Babak Eliassi-Rad, MD
8:05 AMUpdate on Diabetic Retinopathy: How to Achieve 20/20 in 2022 - Nicole H. Siegel, MD 
8:20 AMReducing the Treatment Burden in Chorioretinal Vascular Disease - Steven Ness, MD 
8:35 AMOcular Biomarkers in Alzheimer’s Disease  - Manju Subramanian MD, FACS
8:50 AMHaimovici Lecture Introduction - Edward B. Feinberg, MD, MPH
8:55 AM2022 Haimovici Lecture:  Novel Biomarkers of Age-Related Macular Degeneration - Deeba Husain MD
9:35 AMHaimovici Lecture Award 
9:45 AMBreak
10:10 AMManagement of Age-Related Macular Degeneration - Deeba Husain, MD
10:50 AMRetina Fellow Case Presentations - Joshua Agranat, MD and Samaneh Davoudi, MD
11:20 AMAdjourn
AC Hotel by Marriott Boston Downtown
225 Albany Street
Boston, MA 02118
United States
+1 (617) 848-9063

European soul and design at our Ink Block hotel in Boston

Connect to the city in a new way at AC Hotel Boston Downtown, a hotel in Boston, MA located at the intersection of past and present, revolution and academia, rich culture and sports-fueled pride. Thoughtful service & modern mindset define our hotel near Tufts University where every element is tailored for harmony in your Boston travels. Our amenities include European-inspired breakfast, free WiFi, 50-inch TVs, flexible workspace and mini-fridges. We also offer a 24-hour fitness center, business services, and meeting spaces for 5 to 140 guests. Find a great selection of quick snacks in the AC Store or join us in the AC Lounge for a nightly selection of tapas-inspired bites. Since we cater to travelers looking to immerse themselves in the energy of downtown, know that from our South End Boston hotel you’re minutes to the heart of the city – to attractions, theater, universities & convention centers, as well as the airport. Welcome to an elevated state of mind.

Program Directors

Stephen P. Christiansen, MD
Professor and Chair
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Babak Eliassi-Rad, MD
Director, Glaucoma Service
Assistant Professor of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Faculty

Christine Ament, MD
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Joshua Agranat, MD
Fellow 
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Samaneh Davoudi, MD
Fellow 
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Manishi A. Desai, MD
Assistant Professor
Director of Glaucoma Fellowship
Director of International Education
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Alberto Distefano, MD
Assistant Professor, Department of Ophthalmology
Boston University School of Medicine
Director of Oculoplastic Reconstructive and Orbital Surgery
Neuro-ophthalmology

Deeba Husain MD
Associate Professor Ophthalmology
Harvard Medical School
Investigator Angiogenesis Laboratory
Retina Service
Massachusetts Eye and Ear Infirmary

Haben F. Kefella, MD, MHS
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Anna C. Kupcha, MD
Assistant Professor, Oculoplastics Service
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

KC LaMattina, MD
Assistant Professor
Director of Uveitis Service
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Kambiz Negahban, MD    
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Steven Ness, MD 
Assistant Professor of Ophthalmology, 
Boston University School of Medicine
Director of Retina Service,
Boston University Eye Associates
Attending Physician,
VA Boston Healthcare System

Rachel Robbins, MD
Assistant Professor
Department of Ophthalmology
Boston University School of Medicine/Boston Medical Center

Nicole Hauptman Siegel, MD
Vitreoretinal Disease and Surgery
Assistant Professor of Ophthalmology
Vice Chair of Education, Department of Ophthalmology
Program Director, Ophthalmology Residency
Boston University School of Medicine/Boston Medical Center

Manju Subramanian MD, FACS
Vitreoretinal Disease and Surgery
Associate Professor of Ophthalmology
Vice-Chair for Faculty Affairs
Boston University School of Medicine/Boston Medical Center

Program Manager

Claire P. Grimble, CMP

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program has been submitted to IJCAHPO for consideration of CE credit.

COPE Course ID: 77697-GO
Qualified Credit: 3.25 hour(s) 
Course: 2022 Boston University Ophthalmology Update and Haimovici Symposium Day 1
COPE Activity ID#123764


COPE Course ID: 77701-TD
Qualified Credit: 2.25 hour(s) 
Course: 2022 Boston University Ophthalmology Update and Haimovici Symposium Day 2
COPE Activity ID#123764

Available Credit

  • 5.50 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Live activity for a maximum of 5.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 5.50 Participation

This program is supported in part by educational grants from:

  • Alcon Vision, LLC
  • Genentech, Inc.
  • Horizon Therapeutics USA , Inc.
  • This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 

The following will be exhibiting at the meeting:

  • Alcon
  • Allergan
  • Glaukos
  • Heidelberg Engineering, Inc.
  • Horizon Therapeutics USA , Inc.
  • New World Medical
  • Sanofi
  • SightSciences

 

Price

Cost:
$250.00
Please login or register to take this course.

Registration Fees

MD/DO Two Days$250
MD/DO One Day$125
BUSM/BMC Staff Two Days$0
BUSM/BMC Staff One Day$0
Allied Healthcare Two Days$150
Allied Healthcare One Day$75

BU/BMC Alumni are 20% off.  Please use coupon code ALUMNI20 at checkout

To pay by check, please create an account and email us at cme@bu.edu or call 617-358-5005 and we will assist you.

Cancellation Policy

Substitutions may be made at any time without an additional charge. Refunds, less an $50 administrative fee, will be issued for all cancellations received two weeks prior to the start of the meeting. Should cancellation occur within the two-week window, a credit will be issued, not a refund. Credits will be honored for up to two years. “No shows” are subject to the full course fee. Cancellations/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation.

Special Services / Dietary Needs

Boston University strives to be accessible, inclusive and diverse in our facilities, programming and academic offerings. Your experience in this event is important to us. If you have a disability, require communication access services for the deaf or hard of hearing, or believe that you require a reasonable accommodation for another reason please contact the BUSM-CME Office at least 3 weeks prior to event to discuss your needs.  For in person meetings with meals, we will work to accommodate dietary requests (including, but not limited to: kosher, vegetarian, low cholesterol, and low sodium) received in writing at least three weeks prior to the start of the conference.  Please contact us at cme@bu.edu

Please Note
The conference organizers may take pictures or record videos during the conference. In registering for the conference, you acknowledge that BUSM may photograph you during the meeting, and you agree that we may include images of yourself, intact or in part, for conference promotional activities or other related endeavors. This material may also appear on the conference's website or associated social media outlets. If you do not wish to be photographed, please let the BUSM representative onsite know

COVID-19 Safety Precautions

Update 4/4 - Masks will be required in the meeting areas with the exception of the exhibitor and break areas where masks are encouraged but optional." All attendees will be expected to be up to date on COVID-19 vaccinations.

Please note we will be following all Boston University and City of Boston event and meeting protocols to ensure the health and safety of all attendees, staff, and the local community and will update all attendees on these protocols as we get closer to the meeting date.  In person attendees must attest that they have been fully vaccinated (14 days since last dose) before attending the meeting.  If you will not be fully vaccinated or feel ill on the day, we respectfully ask that you do not attend the meeting (a refund will be issued.)

Unauthorized Registration Sites

Registration for courses managed by BUSM-CME can only be completed through our website at https://cme.bu.edu. Course registrations made through other sites cannot be honored. BUSM-CME is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com

Please report any unauthorized websites or solicitations for registrations to cme@bu.edu.